2025 CPT code 92977

Thrombolysis, coronary; by intravenous infusion.

This code should not be reported with codes for intracoronary thrombolysis (92975). If both intravenous and intracoronary thrombolysis are performed, only the intracoronary code (92975) should be reported. Additionally, it should not be used with diagnostic coronary angiography codes (93454-93461) or injection procedure codes (93563-93564) unless specific criteria are met, such as a significant change in the patient's condition or inadequate visualization of the anatomy.

Modifiers may be applicable to this code to indicate specific circumstances, such as reduced services (modifier 52), distinct procedural service (modifier 59), or repeat procedure (modifiers 76, 77).

Medical necessity for this procedure is established by the presence of a coronary thrombosis causing acute symptoms or threatening significant cardiac dysfunction. The documentation must support the diagnosis and the need for thrombolytic therapy.

The physician is responsible for prepping and anesthetizing the patient, accessing the vein, administering the thrombolytic agent, monitoring the patient during and after the infusion, and managing any complications.

IMPORTANT (For thrombolysis of vessels other than coronary, see 37211-37214) (For cerebral thrombolysis, use 37195) (For thrombolysis, coronary; by intracoronary infusion, including selective coronary angiography, use 92975)

In simple words: This procedure involves dissolving a blood clot in a heart artery by injecting a clot-busting medication into a vein, typically done during a heart attack to quickly restore blood flow.

This code describes the administration of a thrombolytic agent through intravenous infusion to treat coronary thrombosis. This method involves injecting a thrombolytic agent, such as urokinase, into a vein to dissolve blood clots in the coronary arteries, often used in cases of myocardial infarction (heart attack). This procedure includes the work of accessing the vein, administering the thrombolytic agent, and monitoring the patient's condition. The procedure aims to restore blood flow in the coronary arteries and minimize damage to the heart muscle.

Example 1: A patient presents to the emergency department with chest pain and ST-segment elevation on their EKG, indicative of an acute myocardial infarction. The physician decides to administer a thrombolytic agent intravenously to dissolve the clot and restore blood flow to the affected coronary artery., A patient with a history of coronary artery disease experiences sudden onset of chest pain and shortness of breath. The EKG shows changes suggestive of a coronary thrombosis. The physician administers a thrombolytic agent intravenously to treat the blockage., A patient undergoing a cardiac catheterization develops a coronary thrombosis during the procedure. The interventional cardiologist administers a thrombolytic agent intravenously to dissolve the clot and restore blood flow.

Documentation should include the diagnosis of coronary thrombosis, the type and dosage of the thrombolytic agent administered, the method of administration (intravenous infusion), the patient's response to treatment, and any complications encountered. Any discarded portion of the drug must be documented, including the amount wasted and the reason for wastage.

  • Revenue Code: P2F - MAJOR PROCEDURE, CARDIOVASCULAR - OTHER
  • Payment Status: Active
  • Specialties:Cardiology, Emergency Medicine, Interventional Cardiology
  • Place of Service:Inpatient Hospital, Emergency Room - Hospital, Office
** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.